Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Pfizer

You Can Stop Looking, Here's the Perfect Stock for the Current Market

While technology stocks continue to struggle, stocks in the lucrative over-the-counter healthcare products sector are thriving. One prominent such name is Haleon. Its stock has jumped more than 22% over the past three months, as sales and profits in its nine large-scale multinational, high-margin 'power brands' continue to hold leading…

Barchart

Is Pfizer Stock Underperforming the Dow?

Although Pfizer underperformed the Dow Jones this year, analysts are moderately bullish on the stock’s prospects.

Barchart

COVID-19, flu and RSV shots − an epidemiologist explains why all three matter this fall

The Food and Drug Administration approved and granted emergency use authorization on Aug. 22, 2024, for the newest, updated version of the COVID-19 vaccine. The Centers for Disease Control and Prevention quickly endorsed the new shot to protect against severe illness.

The Conversation

From analysis to the latest developments in health,
read the most diverse news in one place.

New COVID vaccines are here. What to know about 2024–25 shots as summer surge continues

Citing skyrocketing COVID spread, the FDA announced in late August that it had approved Pfizer’s Comirnaty and Moderna’s Spikevax vaccines early.

Fortune

When is Canada launching new Covid vaccines targeting KP.2 variant? All you want to know

Close on the heels of US approving vaccines to fight KP.2 variant of Omicron, Health Canada has said they are reviewing updated vaccines that target the strain currently in circulation. The health regulator has said the review process will be completed by early autumn, post which the vaccines will be…

The Times of India

A new Covid vaccine is available. Here’s why some people might not want it right away

Updated Covid vaccines were approved by the FDA earlier this month

The Independent UK

FDA Approves Updated Covid-19 Vaccines From Moderna And Pfizer

FDA approves updated Covid-19 vaccines from Moderna and Pfizer/BioNTech to enhance protection against current variants and combat rising cases.

Top News

Pfizer's Dividend Yield Surpasses 6% Mark, Attracting Investors

Learn about the role of dividends in stock market returns and the significance of sustainable yields, using Pfizer as an example.

The Independent UK

Pfizer CEO on moving beyond COVID vaccines to become a leader in cancer and obesity treatments

Pfizer's CEO Albert Bourla is trying to reposition the global pharmaceutical giant for a post-pandemic world

Barchart

2 Dividend Stocks to Buy in August If the Market Crash Scares You

Volatility is back on Wall Street, which is bound to scare some investors. Meanwhile, Pfizer and Starbucks are two high dividend names with limited downside which conservative investors can consider now.

Get all your
news in one place.

100’s of premium titles.
One news app.

LiveScience

CDC issues new guidelines for RSV vaccines, citing side-effect concerns

The CDC has clarified and narrowed its recommendations for which older adults should get an RSV vaccine.

The Independent UK

About half of US state AGs went on France trip sponsored by group with lobbyist and corporate funds

About half the U.S. state attorneys general have traveled to France for an event cosponsored by a group largely funded by companies

Barchart

Is Wall Street Bullish or Bearish on Pfizer Stock?

Pfizer has underperformed relative to the broader market over the past year, yet Wall Street analysts remain moderately bullish about the stock’s outlook.

Kiplinger

Stock Market Today: Nasdaq Slumps Ahead of Microsoft Earnings

The S&P 500 also closed lower Tuesday, while the Dow Jones Industrial Average managed a win.

Kiplinger

Pfizer Stock Slips After Beat-And-Raise Quarter: What to Know

Pfizer reported a notable year-over-year decline in Q2 earnings, but the results still beat expectations. Here's what investors should know.

Barchart

S&P Futures Tick Higher Ahead of FOMC Meeting, U.S. JOLTs Report and Microsoft Earnings in Focus

September S&P 500 E-Mini futures (ESU24) are trending up +0.17% this morning as market participants braced for the start of the Federal Reserve’s two-day policy meeting while also awaiting the latest reading on U.S. job openings as well as an earnings report from tech giant Microsoft.

Barchart

1 High-Yield Dividend Stock to Buy and Hold

Pfizer's stock shows signs of a potential rebound, buoyed by recent pipeline successes in hemophilia and obesity treatments, an attractive 5% dividend yield, and a rock-bottom valuation. This makes it an appealing dividend stock for value and income investors as the drug giant prepares to report earnings.

1 … 13 14 15 16

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Dow Jones Industrial Average

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.